Rapport Therapeutics CEO Abraham Ceesay sells 51,499 shares worth $2.41 million
Reuters2026/08/12 20:36- Rapport Therapeutics CEO Abraham Ceesay sold 51,499 common shares on Aug. 10-11.
- Sales prices ranged from USD 45.97 to USD 48.62 per share.
- Directly held stake fell to 486,108 shares.
- Indirect holdings totaled 102,458 shares through family trusts.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS lowers Ciena target price to $394
EUR/USD Price Forecast: Holds key 100-day SMA at start of the US CPI week
Malaysia Govt Spending Plan Could Help 99 Speed Mart Retail -- Market Talk
Paying the price for supporting the yen? Japan's foreign reserves fell by $87.8 billions in August, possibly due to selling US Treasuries for funding.
Japanese authorities may have used part of their foreign exchange reserves, including foreign securities such as U.S. Treasury bonds, over the past month to fund record-sized foreign exchange intervention operations.
Crypto prices
More
